XBiotech Inc.
XBIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $427 | $0 | $0 | $0 |
| Gross Profit | -$427 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $5,080 | $5,336 | $11,619 | $7,821 |
| G&A Expenses | $0 | $1,000 | $1,931 | $927 |
| SG&A Expenses | $540 | $1,000 | $1,931 | $927 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5,620 | $6,336 | $13,550 | $8,748 |
| Operating Income | -$6,047 | -$6,336 | -$13,550 | -$8,748 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $141 | $4,608 | $2,695 | -$1,801 |
| Pre-Tax Income | -$5,906 | -$1,728 | -$10,855 | -$10,549 |
| Tax Expense | $102 | $28 | $29 | -$41 |
| Net Income | -$6,008 | -$1,756 | -$10,884 | -$10,508 |
| % Margin | – | – | – | – |
| EPS | -0.2 | -0.058 | -0.36 | -0.34 |
| % Growth | -247.2% | 84% | -5.9% | – |
| EPS Diluted | -0.2 | -0.058 | -0.36 | -0.34 |
| Weighted Avg Shares Out | 30,488 | 30,488 | 30,488 | 30,461 |
| Weighted Avg Shares Out Dil | 30,488 | 30,488 | 30,488 | 30,461 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,427 | $1,530 | $1,504 | $2,096 |
| Interest Expense | $0 | $0 | $88 | $204 |
| Depreciation & Amortization | $427 | $439 | $442 | $439 |
| EBITDA | -$5,479 | -$1,289 | -$10,325 | -$9,906 |
| % Margin | – | – | – | – |